HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average. - Labban, M; Mali, P; Jao, R; Patel, P (Value in Health, 2022)